Revista Portuguesa De Cardiologia最新文献

英文中文

Cardiovascular benefits of resistance exercise: It's time to prescribe 阻力运动对心血管的益处：是时候开处方了。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-10-01 DOI: 10.1016/j.repc.2024.02.009

Despite the well-known health benefits of regular physical activity, sedentary behavior and physical inactivity remain a real global pandemic. Exercise is associated with increased life expectancy, improved quality of life and prevention of multiple diseases. Although less implemented in practice compared to aerobic exercise, recent evidence shows that resistance exercise (RE) is also responsible for various benefits, including improvements in body composition, control of several cardiovascular (CV) risk factors, and reduction of CV outcomes. RE increases strength and muscle mass, is effective in controlling type 2 diabetes, and improves the management of obesity, lipids, and blood pressure profiles. In this setting, clinical guidelines recommend the inclusion of RE for primary and secondary CV risk prevention, particularly in combination with aerobic exercise, in which the benefits are most pronounced. Prescription of RE should follow a methodology that includes key variables such as frequency, intensity, type, time, and progression. Despite challenges, professionals in the CV field should be familiar with RE prescription in order to maximize its referral in clinical practice. This review aims to analyze the CV effects of RE and current recommendations regarding the prescription of this type of exercise.

尽管经常进行体育锻炼对健康的益处众所周知，但久坐不动和缺乏体育锻炼仍是全球的一个现实问题。运动与延长预期寿命、提高生活质量和预防多种疾病有关。虽然与有氧运动相比，阻力运动（RE）在实践中开展得较少，但最近的证据显示，阻力运动（RE）也能带来各种益处，包括改善身体成分、控制多种心血管（CV）风险因素和减少 CV 后果。阻力运动能增强力量和肌肉质量，有效控制 2 型糖尿病，改善肥胖、血脂和血压状况。在这种情况下，临床指南建议将 RE 纳入一级和二级心血管风险预防，尤其是与有氧运动相结合，因为有氧运动的益处最为明显。RE 的处方应遵循包括频率、强度、类型、时间和进展等关键变量的方法。尽管存在挑战，但心血管领域的专业人士仍应熟悉 RE 的处方，以便在临床实践中最大限度地推广它。本综述旨在分析 RE 对心血管疾病的影响，以及目前有关此类运动处方的建议。

{"title":"Cardiovascular benefits of resistance exercise: It's time to prescribe","authors":"","doi":"10.1016/j.repc.2024.02.009","DOIUrl":"10.1016/j.repc.2024.02.009","url":null,"abstract":"<div><div>Despite the well-known health benefits of regular physical activity, sedentary behavior and physical inactivity remain a real global pandemic. Exercise is associated with increased life expectancy, improved quality of life and prevention of multiple diseases. Although less implemented in practice compared to aerobic exercise, recent evidence shows that resistance exercise (RE) is also responsible for various benefits, including improvements in body composition, control of several cardiovascular (CV) risk factors, and reduction of CV outcomes. RE increases strength and muscle mass, is effective in controlling type 2 diabetes, and improves the management of obesity, lipids, and blood pressure profiles. In this setting, clinical guidelines recommend the inclusion of RE for primary and secondary CV risk prevention, particularly in combination with aerobic exercise, in which the benefits are most pronounced. Prescription of RE should follow a methodology that includes key variables such as frequency, intensity, type, time, and progression. Despite challenges, professionals in the CV field should be familiar with RE prescription in order to maximize its referral in clinical practice. This review aims to analyze the CV effects of RE and current recommendations regarding the prescription of this type of exercise.</div></div>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":"43 10","pages":"Pages 573-582"},"PeriodicalIF":1.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines 对 "即将发布的指南中的心肿瘤指南、结构性心脏病和库尼斯综合征 "一信的回复。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-10-01 DOI: 10.1016/j.repc.2024.03.003

引用次数: 0

Superdominant circumflex as culprit of inferior myocardial infarction. 下心肌梗死的罪魁祸首是超优势环状静脉。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-19 DOI: 10.1016/j.repc.2024.07.009

Joana Lima Lopes, Luís Brízida, João Bicho Augusto

引用次数: 0

Of mice and man 老鼠与人类

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-10 DOI: 10.1016/j.repc.2024.09.001

Manuela Fiuza

引用次数: 0

Training and attitudes concerning cardiac rehabilitation in Portugal: A national survey of physician members of the Portuguese Society of Cardiology 葡萄牙有关心脏康复的培训和态度：对葡萄牙心脏病学会医生成员的全国调查。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2023.12.009

Introduction and Objectives

Cardiac rehabilitation (CR) is a central component in the management of cardiovascular disease. While its potential benefits have been extensively explored and confirmed, its implementation is still suboptimal, due to various possible barriers. This study aimed to assess training and attitudes concerning CR among physicians in a Portuguese setting.

Methods

An online questionnaire structured in three parts (participant characteristics, training and attitudes concerning CR, and a brief general knowledge assessment) was developed and sent to members of the Portuguese Society of Cardiology. The study population encompassed physicians with a medical specialty or residents from the third year onward of a specialty program.

Results

A total of 97 individuals (57.7% male, 61.9% aged ≤50 years) presented valid answers. CR was available at the workplace of 54.6% of participants. Most of them considered that the time allocated to CR training during residency was inadequate, and thought that more time was needed for this purpose. Most had not dedicated (or intended to dedicate) time for CR training, with lack of time being the most frequently attributed reason. In terms of referral, a substantial proportion of subjects did not refer patients, with lack of CR centers and human resources being the most frequent reasons.

Conclusions

This survey provides contemporary data on CR training and attitudes, highlighting areas of potential improvement, such as time allocated to training in this area. These results could provide a useful pragmatic framework for optimization of training and awareness in this pivotal field of cardiovascular medicine.

导言和目标：心脏康复（CR）是心血管疾病治疗的核心组成部分。虽然其潜在益处已得到广泛探讨和证实，但由于各种可能的障碍，其实施情况仍不理想。本研究旨在评估葡萄牙医生对 CR 的培训情况和态度：研究开发了一份在线调查问卷，分为三个部分（参与者特征、关于 CR 的培训和态度以及简短的常识评估），并发送给葡萄牙心脏病学会的成员。研究对象包括医学专业医生或专业课程三年级以上的住院医师：共有 97 人（57.7% 为男性，61.9% 年龄在 50 岁以下）提供了有效答案。54.6%的参与者在工作场所有 CR。他们中的大多数人认为，在住院实习期间分配给 CR 培训的时间不够，并认为需要为此投入更多的时间。大多数人没有（或不打算）专门拨出时间进行 CR 培训，最常见的原因是缺乏时间。在转诊方面，相当一部分受试者没有转诊病人，缺乏 CR 中心和人力资源是最常见的原因：这项调查提供了有关 CR 培训和态度的最新数据，突出了可能需要改进的领域，例如分配给该领域培训的时间。这些结果可为优化心血管医学这一关键领域的培训和认识提供一个有用的实用框架。

{"title":"Training and attitudes concerning cardiac rehabilitation in Portugal: A national survey of physician members of the Portuguese Society of Cardiology","authors":"","doi":"10.1016/j.repc.2023.12.009","DOIUrl":"10.1016/j.repc.2023.12.009","url":null,"abstract":"<div><h3>Introduction and Objectives</h3><p>Cardiac rehabilitation (CR) is a central component in the management of cardiovascular disease. While its potential benefits have been extensively explored and confirmed, its implementation is still suboptimal, due to various possible barriers. This study aimed to assess training and attitudes concerning CR among physicians in a Portuguese setting.</p></div><div><h3>Methods</h3><p>An online questionnaire structured in three parts (participant characteristics, training and attitudes concerning CR, and a brief general knowledge assessment) was developed and sent to members of the Portuguese Society of Cardiology. The study population encompassed physicians with a medical specialty or residents from the third year onward of a specialty program.</p></div><div><h3>Results</h3><p>A total of 97 individuals (57.7% male, 61.9% aged ≤50 years) presented valid answers. CR was available at the workplace of 54.6% of participants. Most of them considered that the time allocated to CR training during residency was inadequate, and thought that more time was needed for this purpose. Most had not dedicated (or intended to dedicate) time for CR training, with lack of time being the most frequently attributed reason. In terms of referral, a substantial proportion of subjects did not refer patients, with lack of CR centers and human resources being the most frequent reasons.</p></div><div><h3>Conclusions</h3><p>This survey provides contemporary data on CR training and attitudes, highlighting areas of potential improvement, such as time allocated to training in this area. These results could provide a useful pragmatic framework for optimization of training and awareness in this pivotal field of cardiovascular medicine.</p></div>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":"43 9","pages":"Pages 487-496"},"PeriodicalIF":1.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S087025512400074X/pdfft?md5=07b25b7e26ada5b51786d0588283fd8f&pid=1-s2.0-S087025512400074X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140068870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Giant pleuropericardial cyst: An unexpected finding 巨大胸膜囊肿：意外发现

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2024.02.010

引用次数: 0

The balance between thrombosis and bleeding after mitral valve surgery: The need for robust evidence 二尖瓣手术后血栓形成与出血之间的平衡：需要强有力的证据。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2024.07.004

Rui Azevedo Guerreiro

引用次数: 0

Exploring the evidence gap: Loop diuretic withdrawal in chronic heart failure 探索证据差距：慢性心力衰竭患者停用环利尿剂。

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2024.07.005

Aurora Andrade

引用次数: 0

Loop diuretic discontinuation in chronic heart failure patients: A retrospective study 慢性心力衰竭患者停用环利尿剂：回顾性研究

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2024.02.012

Introduction and Objectives

The use of loop diuretics is central in managing congestion in heart failure (HF), but their impact on prognosis remains unclear. In euvolemic patients, dose reduction is recommended, but there is no recommendation on their discontinuation. This study aims to assess the impact of loop diuretic discontinuation on the prognosis of outpatients with HF with reduced ejection fraction.

Methods

This retrospective cohort study collected data from medical records of patients followed in an outpatient HF clinic at a university hospital center. Patients were included if they had been on loop diuretics and these were discontinued. Demographic, clinical and laboratory data were collected, and number and type of congestive events during the one-year period after discontinuation were recorded.

Results

Among 265 patients on loop diuretics, almost half (129) discontinued them at some point. Patients had optimized medical therapy, low median age, low New York Heart Association class, low B-type natriuretic peptide values, normal blood pressure, controlled heart rate and kidney function within normal limits. Among 122 patients with one year of follow-up, 18 (14.8%) had a congestive event. Fifteen events (83.3%) were low-dose diuretic reinitiation at a scheduled visit. There were only three worsening heart failure events (2.5%) during the one-year period. A significant improvement in kidney function from discontinuation to the one-year follow-up appointment was also observed.

Conclusions

In our cohort, loop diuretic discontinuation was possible and safe in a large proportion of patients. The results should be interpreted with caution and cannot be extrapolated to a broader population of HF patients.

引言和目的：使用襻利尿剂是控制心力衰竭（HF）充血的关键，但其对预后的影响仍不明确。对于血容量不足的患者，建议减少襻利尿剂的剂量，但没有关于停用襻利尿剂的建议。本研究旨在评估停用襻利尿剂对射血分数降低型心力衰竭门诊患者预后的影响：这项回顾性队列研究从一家大学医院中心心房颤动门诊随访患者的病历中收集数据。曾使用襻利尿剂但已停药的患者也被纳入研究范围。研究人员收集了患者的人口统计学、临床和实验室数据，并记录了停药后一年内充血性事件的数量和类型：结果：在 265 名使用襻利尿剂的患者中，近一半（129 人）在某一阶段停用了襻利尿剂。患者接受了最佳的药物治疗，年龄中位数较低，纽约心脏协会分级较低，B 型钠尿肽值较低，血压正常，心率受控，肾功能在正常范围内。在随访一年的 122 名患者中，18 人（14.8%）发生了充血性事件。其中 15 例（83.3%）是在预约就诊时重新使用小剂量利尿剂。在一年的随访期间，仅发生了三起心衰恶化事件（2.5%）。从停药到一年随访期间，肾功能也有明显改善：在我们的队列中，大部分患者都可以停用襻利尿剂，而且停用襻利尿剂是安全的。结论：在我们的队列中，很大一部分患者可以停用襻利尿剂，而且停药安全，但对结果的解释应谨慎，不能将其推广到更广泛的高血压患者群体中。

{"title":"Loop diuretic discontinuation in chronic heart failure patients: A retrospective study","authors":"","doi":"10.1016/j.repc.2024.02.012","DOIUrl":"10.1016/j.repc.2024.02.012","url":null,"abstract":"<div><h3>Introduction and Objectives</h3><p>The use of loop diuretics is central in managing congestion in heart failure (HF), but their impact on prognosis remains unclear. In euvolemic patients, dose reduction is recommended, but there is no recommendation on their discontinuation. This study aims to assess the impact of loop diuretic discontinuation on the prognosis of outpatients with HF with reduced ejection fraction.</p></div><div><h3>Methods</h3><p>This retrospective cohort study collected data from medical records of patients followed in an outpatient HF clinic at a university hospital center. Patients were included if they had been on loop diuretics and these were discontinued. Demographic, clinical and laboratory data were collected, and number and type of congestive events during the one-year period after discontinuation were recorded.</p></div><div><h3>Results</h3><p>Among 265 patients on loop diuretics, almost half (129) discontinued them at some point. Patients had optimized medical therapy, low median age, low New York Heart Association class, low B-type natriuretic peptide values, normal blood pressure, controlled heart rate and kidney function within normal limits. Among 122 patients with one year of follow-up, 18 (14.8%) had a congestive event. Fifteen events (83.3%) were low-dose diuretic reinitiation at a scheduled visit. There were only three worsening heart failure events (2.5%) during the one-year period. A significant improvement in kidney function from discontinuation to the one-year follow-up appointment was also observed.</p></div><div><h3>Conclusions</h3><p>In our cohort, loop diuretic discontinuation was possible and safe in a large proportion of patients. The results should be interpreted with caution and cannot be extrapolated to a broader population of HF patients.</p></div>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":"43 9","pages":"Pages 513-522"},"PeriodicalIF":1.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0870255124001847/pdfft?md5=cc45c1d91bcd328d608e6d1ff4cc54e9&pid=1-s2.0-S0870255124001847-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Left atrial appendage thrombus in severe mitral stenosis: Can chamber morphology and thrombus location influence therapeutic choice? 严重二尖瓣狭窄的左心房附壁血栓：心腔形态和血栓位置会影响治疗选择吗？

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Revista Portuguesa De Cardiologia

Pub Date : 2024-09-01 DOI: 10.1016/j.repc.2024.07.001

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Revista Portuguesa De Cardiologia

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀